Signal Transduction and Targeted Therapy (ISSN 2059-3635 (online), ISSN 2095-9907 (print), CN 51-1758/R) is a new open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, including but not limited to: cancer, cardiovascular diseases, autoimmune diseases, and nervous system diseases.
To an extent, all life scientists are geneticists because genetic technology and the accumulation of genomic information have enriched all of biology. You may or may not call yourself a geneticist, but if you work on or with genes you need to know about the latest developments. Nature Reviews Genetics covers the full scientific breadth of modern genetics, capturing its excitement, diversity and implications.
Subjects Covered:
-Genomics: genome sequencing, genome projects, bioinformatics, cancer genomics, metagenomics, pharmacogenomics, resources-
Functional genomics: transcriptomics, functional genomics screens, bioinformatics-
Evolutionary genetics: evo-devo, genome evolution, comparative genomics, population genetics, phylogenetics-
Technology: new techniques, experimental strategies, therapy, applied genetics and genomics, computational biology-
Gene expression: gene regulatory elements, transcriptional and post-transcriptional regulation, regulatory RNAs, broad perspectives on gene regulation, gene expression profiling, gene regulatory networks-
Multifactorial genetics: complex traits, mapping strategies, technology, genetic variation-
Disease: disease gene identification, relationship between genotype and phenotype, molecular pathology of genetic disease, complex disease, disease susceptibility/resistance-
Chromosome biology: DNA elements, telomeres, centromeres, mobile elements, chromosome stability, DNA damage, meiosis and mitosis, nuclear organization, artificial chromosomes-
Epigenetics: DNA methylation, histone modification, chromatin structure, imprinting, chromatin remodeling, epigenomics-
Developmental biology: patterning, differentiation, stem cells, reproductive technology-
Systems and networks: systems biology, biological networks, synthetic biology, modelling-
Ethical, legal and social implications of genetics and genomics
Springer Nature•ISSN: 1061-4036 / 1546-1718•United States
25.5
Clarivate IF
Nature Genetics publishes the very highest quality research in genetics. It encompasses genetic and functional genomic studies on human and plant traits and on other model organisms. Current emphasis is on the genetic basis for common and complex diseases and on the functional mechanism, architecture and evolution of gene networks, studied by experimental perturbation.
Integrative genetic topics comprise, but are not limited to:
-Genes in the pathology of human disease
-Molecular analysis of simple and complex genetic traits
-Cancer genetics
-Agricultural genomics
-Developmental genetics
-Regulatory variation in gene expression
-Strategies and technologies for extracting function from genomic data
-Pharmacological genomics
-Genome evolution
-Nature Genetics
The Journal of Human Genetics is an international journal publishing articles on human genetics, including medical genetics and human genome analysis. It covers all aspects of human genetics, including molecular genetics, clinical genetics, behavioral genetics, immunogenetics, pharmacogenomics, population genetics, functional genomics, epigenetics, genetic counseling and gene therapy.
Articles on the following areas are especially welcome: genetic factors of monogenic and complex disorders, genome-wide association studies, genetic epidemiology, cancer genetics, personal genomics, genotype-phenotype relationships and genome diversity.
The goal of this journal is to publish cutting-edge reviews on subjects pertinent to all aspects of stem cell research, therapy, ethics, commercialization, and policy. We aim to provide incisive, insightful, and balanced contributions from leading experts in each relevant domain that will be of immediate interest to a wide readership of clinicians, basic scientists, and translational investigators.
We accomplish this aim by appointing major authorities to serve as Section Editors in key subject areas across the discipline. Section Editors select topics to be reviewed by leading experts who emphasize recent developments and highlight important papers published over the past year on their topics, in a crisp and readable format. We also provide commentaries from well-known figures in the field, and an Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research.
The journal publishes original, peer-reviewed articles on new and significant advances in all aspects of cell and chromosome research. Timely and substantial articles in the areas of cell biology, genetic toxicology, chromosome evolution, cytogenetics; molecular-, population- and evolutionary genetics; epigenetics; developmental and stress biology; transcriptomics, structural and functional genomics, proteomics, metabolomics, integrated omics and use of tools of bioinformatics in the areas stated herein. Studies demonstrating the use of modern approaches such as genome editing to address technological problems and/or biological questions pertaining to the research areas mentioned above are encouraged. However, the studies should be conducted with appropriate scientific rigor in the design, conduct, validity, and interpretation of results to ensure reliability and reproducibility of the data presented. The papers must be written concisely and be of interest to a broad audience.
The journal also publishes comprehensive reviews on current developments and future trends in cell and chromosome research. Such articles should be authoritative, covering all the aspects of a chosen topic, and serve as a resource for students, researchers, and multidisciplinary audience. Authors are welcome to contact the Editor-in-Chief to discuss their topic of interest while preparing a prospective review article.
Thematic special issues on cutting edge research in the development of the above stated areas are periodically published by the journal. Articles for such issues are commissioned by the respective topic editor/s.
Human Genome Variation is a leading international peer-reviewed journal publishing original research, clinical updates, and reviews indexed in Clarivate Web of Science (SCIE) with Q4 quartile ranking.